HUP9900612A2 - Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra - Google Patents
Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásraInfo
- Publication number
- HUP9900612A2 HUP9900612A2 HU9900612A HUP9900612A HUP9900612A2 HU P9900612 A2 HUP9900612 A2 HU P9900612A2 HU 9900612 A HU9900612 A HU 9900612A HU P9900612 A HUP9900612 A HU P9900612A HU P9900612 A2 HUP9900612 A2 HU P9900612A2
- Authority
- HU
- Hungary
- Prior art keywords
- estrogen
- correcting
- hormonal medicaments
- progesterone
- oestrogen deficiencies
- Prior art date
Links
- 206010030247 Oestrogen deficiency Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000003054 hormonal effect Effects 0.000 title 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 6
- 229940011871 estrogen Drugs 0.000 abstract 5
- 239000000262 estrogen Substances 0.000 abstract 5
- 229960003387 progesterone Drugs 0.000 abstract 3
- 239000000186 progesterone Substances 0.000 abstract 3
- VOXZDWNPVJITMN-UHFFFAOYSA-N 13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2C3CCC(C)(C(CC4)O)C4C3CCC2=C1 VOXZDWNPVJITMN-UHFFFAOYSA-N 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 229960004296 megestrol acetate Drugs 0.000 abstract 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940068196 placebo Drugs 0.000 abstract 1
- 239000000902 placebo Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány ösztrőgén/prőgeszterőn elegy alkalmazása klimaktériűmbanlévő nők ösztrőgénhiányős állapőtának kezelésére, 1 hónapőn át egyedülösztrőgén, majd ösztrőgén/prőgeszterőn kőmbináció, végül placebőőrális beadása útján. A fenti ösztrőgén/prőgeszterőn-készítmény 1-3 mgdózisban 17-ösztradiőlt és 1,5-6 mg dózisban nőmegesztről-acetátőttartalmaz. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9509364A FR2737411B1 (fr) | 1995-08-01 | 1995-08-01 | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
PCT/IB1996/000754 WO1997004784A1 (fr) | 1995-08-01 | 1996-07-29 | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9900612A2 true HUP9900612A2 (hu) | 1999-07-28 |
HUP9900612A3 HUP9900612A3 (en) | 1999-11-29 |
HU229843B1 HU229843B1 (en) | 2014-09-29 |
Family
ID=9481610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9900612A HU229843B1 (en) | 1995-08-01 | 1996-07-29 | Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
Country Status (31)
Country | Link |
---|---|
US (1) | US5891867A (hu) |
EP (1) | EP0783310B1 (hu) |
JP (1) | JPH10507207A (hu) |
KR (1) | KR100450649B1 (hu) |
CN (1) | CN1138547C (hu) |
AP (1) | AP829A (hu) |
AR (1) | AR004502A1 (hu) |
AT (1) | ATE225659T1 (hu) |
AU (1) | AU722355B2 (hu) |
BR (1) | BR9606549A (hu) |
CA (1) | CA2201368C (hu) |
CZ (1) | CZ289706B6 (hu) |
DE (1) | DE69624214T2 (hu) |
DK (1) | DK0783310T3 (hu) |
DZ (1) | DZ2078A1 (hu) |
ES (1) | ES2184880T3 (hu) |
FR (1) | FR2737411B1 (hu) |
HK (1) | HK1005227A1 (hu) |
HU (1) | HU229843B1 (hu) |
IL (1) | IL120558A (hu) |
MA (1) | MA23946A1 (hu) |
MX (1) | MX9702381A (hu) |
MY (1) | MY117307A (hu) |
NO (1) | NO312996B1 (hu) |
OA (1) | OA10411A (hu) |
PT (1) | PT783310E (hu) |
RU (1) | RU2188641C2 (hu) |
TN (1) | TNSN96101A1 (hu) |
TW (1) | TW473390B (hu) |
WO (1) | WO1997004784A1 (hu) |
ZA (1) | ZA966545B (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030355A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
US20020151732A1 (en) * | 2001-01-05 | 2002-10-17 | Claes Ohlsson | Estrogen receptors |
EP1390038A2 (en) * | 2001-05-16 | 2004-02-25 | Endeavor Pharmaceuticals | Treatment of conditions relating to hormone deficiencies by administration of progestins |
WO2003049744A1 (en) | 2001-12-05 | 2003-06-19 | Barr Laboratories, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
US7008979B2 (en) * | 2002-04-30 | 2006-03-07 | Hydromer, Inc. | Coating composition for multiple hydrophilic applications |
WO2005007112A2 (en) * | 2003-07-16 | 2005-01-27 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
PE20081895A1 (es) * | 2007-03-26 | 2009-01-26 | Theramex | Regimen anticonceptivo oral |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
FR2695826B1 (fr) * | 1992-09-21 | 1995-01-06 | Theramex | Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention. |
-
1995
- 1995-08-01 FR FR9509364A patent/FR2737411B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-22 MA MA24321A patent/MA23946A1/fr unknown
- 1996-07-26 MY MYPI96003099A patent/MY117307A/en unknown
- 1996-07-29 EP EP96923018A patent/EP0783310B1/fr not_active Expired - Lifetime
- 1996-07-29 RU RU97108279/14A patent/RU2188641C2/ru active
- 1996-07-29 MX MX9702381A patent/MX9702381A/es active IP Right Grant
- 1996-07-29 CZ CZ1997967A patent/CZ289706B6/cs not_active IP Right Cessation
- 1996-07-29 WO PCT/IB1996/000754 patent/WO1997004784A1/fr not_active Application Discontinuation
- 1996-07-29 BR BR9606549A patent/BR9606549A/pt not_active Application Discontinuation
- 1996-07-29 PT PT96923018T patent/PT783310E/pt unknown
- 1996-07-29 US US08/817,329 patent/US5891867A/en not_active Expired - Lifetime
- 1996-07-29 IL IL12055896A patent/IL120558A/en not_active IP Right Cessation
- 1996-07-29 ES ES96923018T patent/ES2184880T3/es not_active Expired - Lifetime
- 1996-07-29 AT AT96923018T patent/ATE225659T1/de active
- 1996-07-29 CN CNB96191100XA patent/CN1138547C/zh not_active Expired - Lifetime
- 1996-07-29 HU HU9900612A patent/HU229843B1/hu unknown
- 1996-07-29 DK DK96923018T patent/DK0783310T3/da active
- 1996-07-29 AP APAP/P/1997/000979A patent/AP829A/en active
- 1996-07-29 KR KR1019970702125A patent/KR100450649B1/ko not_active IP Right Cessation
- 1996-07-29 CA CA2201368A patent/CA2201368C/fr not_active Expired - Lifetime
- 1996-07-29 AU AU63674/96A patent/AU722355B2/en not_active Expired
- 1996-07-29 DE DE69624214T patent/DE69624214T2/de not_active Expired - Lifetime
- 1996-07-29 JP JP9507406A patent/JPH10507207A/ja not_active Ceased
- 1996-07-30 DZ DZ960122A patent/DZ2078A1/fr active
- 1996-07-31 AR ARP960103818A patent/AR004502A1/es not_active Application Discontinuation
- 1996-08-01 ZA ZA966545A patent/ZA966545B/xx unknown
- 1996-08-01 TN TNTNSN96101A patent/TNSN96101A1/fr unknown
- 1996-09-24 TW TW085111673A patent/TW473390B/zh not_active IP Right Cessation
-
1997
- 1997-03-26 NO NO19971449A patent/NO312996B1/no not_active IP Right Cessation
- 1997-04-01 OA OA60985A patent/OA10411A/fr unknown
-
1998
- 1998-05-25 HK HK98104497A patent/HK1005227A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69804918D1 (de) | Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung | |
HUP0104680A2 (hu) | Háromfázisú orális fogamzásgátló | |
KR960704553A (ko) | 적어도 하나의 프로게스토겐과 적어도 하나의 에스트로겐을 함유하는 대용요법용 제제(preparation for substitution therapy containing at least one progestogen and at least one estrogen) | |
ES2033850T3 (es) | Forma farmaceutica consistente en una combinacion dosificada, destinada al tratamiento de las mujeres pre-menopausicas. | |
HUP9900612A2 (hu) | Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra | |
KR970704450A (ko) | 자궁내막증식증 또는 자궁평활근종을 치료하기 위한 프로게스테론 길항제 및 게스타겐의 용도(Use of a Progesterone Antagonist and of a Gestagen for the Treatment of Endometriosis or Leiomyomate Uteri) | |
CA2267743A1 (en) | Low dose estrogen interrupted hormone replacement therapy | |
EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
HUP9904344A2 (hu) | Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kit | |
KR920011514A (ko) | 프로게스토겐만을 함유하는 피임제 | |
HUE030455T2 (hu) | Etinilösztradiol és klórmadinon-acetát kombinációt tartalmazó hormonkészítmény | |
RU97108279A (ru) | Новые гормональные лекарственные препараты и их применение для коррекции эстрогенной недостаточности | |
MY128482A (en) | New hormonal composition and its use | |
ATE278406T1 (de) | Orales contrazeptivum | |
CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
TH27339A (th) | ฮอร์โมนตัวใหม่ที่ใช้เป็นยาและประโยชน์ของมันในการรักษาภาวะขาดเอสโตเจน | |
AU5942700A (en) | Sequential estrogen/progestrone antagonist combination for hormone replacement theapy |